Abstract
A safe and effective malaria vaccine would contribute greatly to the control and prevention of the disease. Although a review of global activity in malaria vaccine development does reflect significant activity, progress has remained slow. This article discusses the current vaccine candidates, with emphasis on those in the clinic, and explains the numerous challenges to making and evaluating malaria vaccines, which have resulted in only a few approaches being adopted and repeatedly evaluated. Against a parasite with more than 5200 genes, the lack of definitive knowledge regarding the nature of protective immunity and absence of reliable surrogates of protection are among the key challenges to a rational evaluation and prioritization of candidate vaccines. Pursuing the current R&D strategies may not result in the availability of a vaccine with characteristics suitable to impact significantly on disease morbidity in developing countries. Therefore, it is critical that the main challenges to malaria vaccine development be unambiguously identified and collectively addressed.
Citations
Feb 6, 2007·Parasitology·T Richie
Jul 8, 2011·Omics : a Journal of Integrative Biology·Gregory A PolandRobert M Jacobson
Apr 14, 2007·Annual Review of Biomedical Engineering·Robert A Malkin
Feb 2, 2011·PloS One·Hema BoraYagya D Sharma
May 24, 2011·Journal of Parasitology Research·Daniel Y BargieriMauricio M Rodrigues
Aug 23, 2012·Journal of Biomedicine & Biotechnology·Marina Clemente, Mariana G Corigliano
Sep 10, 2014·Protein Expression and Purification·Inayat Hussain SheikhNuzhat A Kaushal
Aug 17, 2010·Vaccine·M N ShuaibuK Hirayama
Nov 29, 2008·Vaccine·Zarifah Hussain ReedCarole Long
Jan 30, 2007·Trends in Parasitology·Sócrates HerreraMyriam Arévalo-Herrera
Nov 4, 2006·Biochemical and Biophysical Research Communications·Alvaro MonguiManuel A Patarroyo
Jun 9, 2006·Vaccine·Peter J Hotez, Meghan T Ferris
Oct 19, 2006·Vaccine·Marc P GirardMarie Paule Kieny
Mar 1, 2011·Vaccine·M N ShuaibuK Hirayama
Sep 9, 2011·Memórias do Instituto Oswaldo Cruz·Myriam Arévalo-HerreraSócrates Herrera Valencia
Jun 20, 2008·Expert Review of Vaccines·Blaise Genton
Mar 2, 2016·PloS One·Grant E FrahmMichael J W Johnston
Sep 1, 2007·Current Opinion in Infectious Diseases·Blaise Genton, Zarifah H Reed
Sep 7, 2007·ChemMedChem·Daniel Dive, Christophe Biot
Jun 14, 2008·Clinical and Vaccine Immunology : CVI·David E ArnotAlan W Thomas